Fr. 69.00

Clinical Trials of Antidepressants - How Changing the Model Can Uncover New, More Effective Molecules

Inglese · Tascabile

Spedizione di solito entro 1 a 2 settimane (il titolo viene stampato sull'ordine)

Descrizione

Ulteriori informazioni

This brief guide takes current clinical trial protocols totask and replaces them with a contemporary framework for improvingnext-generation antidepressants and their underlying science. Innovative modelsare based on a nuanced, neurologically-informed understanding of drugmechanisms and the component cognitive, mood, and behavioral aspects ofdepression. The book reconceptualizes not only the clinical trial process butthe clinical concept of depression itself as essential to bringingpharmaceutical research and development up to date, boosting efficiency andeffectiveness, finding new molecules, and reducing waste. Case studies and areview of salient depression scales illustrate the potential benefits of suchwide-scale change. 
Included in the coverage: 

    Why now the need for a new clinical trials model for antidepressants?
  • Aims and basic requirements of clinical trials: conventional and component-specific models.
  • Methods for measuring the components and the profile of drug actions: the multivantaged approach.
  • Achieving the ideal clinical trial: an example of the merged componential and established models.
  • Prediction and shortening the clinical trial.
  • The video clinical trial. 

Clinical Trials ofAntidepressants will interest a varied audience, including clinicalinvestigators, academic and pharmaceutical company scientists, clinical trialorganizations, psychiatrists, outpatient physicians, psychotherapists, clinicalpsychologists, psychology graduate students, medical students, and governmentagencies such as the FDA.

Sommario

Introduction.- Why Now the Need for a New Clinical Trial Model for Antidepressants?.- Reconceptualizing Depression and the Componential-Specific Model of Clinical Trials.- Aims and Basic requirements of Clinical Trials: Conventional and Component-Specific Models.- Methods for Measuring the Components and Profile of Drug Actions: The Multivantaged Approach.- The Component-Specific Model Applied in a Clinical Trial: An Example.- Comparing the Component-Specific Model Directly with the Established Diagnosis-Specific Trial.- Prediction and Shortening the Clinical Trial: Further Advantages of the Component-Specific Model.- The Video Clinical Trial and the VIBES Method.- Conclusions.

Dettagli sul prodotto

Autori Martin M. Katz
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 16.02.2016
 
EAN 9783319264639
ISBN 978-3-31-926463-9
Pagine 66
Dimensioni 148 mm x 238 mm x 8 mm
Peso 143 g
Illustrazioni XV, 66 p. 3 illus. in color.
Serie SpringerBriefs in Psychology
Categorie Scienze umane, arte, musica > Psicologia > Psicologia applicata

C, Method, Health psychology, antidepressants, vibes, Behavioral Science and Psychology, diagnostic-specific model, tricyclic drugs, component-specific model, video technology, multivantaged, dimensions of depression, clinical assessment methods, SSRIs, components of psychopathology

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.